Cell Reprogramming & Therapeutics LLC is focused on the development and commercialization of cell-based technologies to target diseases of the central nervous system. The company’s programs aim to develop cellular models and therapeutics for neurological disorders such as Brain and Spinal cord injuries, Stroke, Parkinson's, Alzheimer's, Amyotrophic Lateral Sclerosis, Huntington's and brain cancers.
Looking for a particular Cell Reprogramming & Therapeutics LLC employee's phone or email?
The Cell Reprogramming & Therapeutics LLC annual revenue was $400000 in 2026.
Arshak Alexanian is the Chief Scientific Officer of Cell Reprogramming & Therapeutics LLC.
3 people are employed at Cell Reprogramming & Therapeutics LLC.
Cell Reprogramming & Therapeutics LLC is based in Wauwatosa, Wisconsin.
The NAICS codes for Cell Reprogramming & Therapeutics LLC are [541714, 54171, 541, 54, 5417].
The SIC codes for Cell Reprogramming & Therapeutics LLC are [87, 873].